**Analysis:**

The earnings call for UnitedHealth Group revealed strong financial performance with 9% revenue growth and 23% earnings per share growth in Q1 2019. The company's focus on improving healthcare affordability, outcomes, and patient experience, known as the "triple aim," has driven this growth. UnitedHealth Group's strategic initiatives in pharmacy care, digital health, and reinventing healthcare delivery have also contributed to its success. The company's outlook for 2019 is positive, with adjusted earnings per share expected to grow by 13% to 15%. However, there are some challenges and uncertainties, such as the potential impact of the health insurance tax deferral and the impact of the Medicare for All proposal. Additionally, the company's strategic growth initiatives may face challenges in the short term. Overall, the stock is likely to face short-term pressure due to these challenges and uncertainties.

**Conclusion:**

The short-term impact on the stock price of UnitedHealth Group is likely to be negative due to the challenges and uncertainties mentioned above. The company's strong financial performance and strategic initiatives may not be enough to offset the potential negative impact of the health insurance tax deferral and the Medicare for All proposal. Therefore, the stock price is likely to face short-term pressure.

[-1]